Evaluation of the Long ‐Term Cost‐Effectiveness of Once‐Weekly semaglutide versus dulaglutide for the treatment of type 2 diabetes mellitus in the UK

Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-.

Source: Diabetes, Obesity and Metabolism - October 26, 2018 Category: Endocrinology Authors: Adie Viljoen, Christina Stentoft Hoxer, Pierre Johansen, Samuel Malkin, Barnaby Hunt, Stephen C Bain Source Type: research